Provided by Tiger Trade Technology Pte. Ltd.

X4 Pharmaceuticals Inc

3.56
-0.1000-2.73%
Post-market: 3.560.00000.00%19:55 EST
Volume:831.85K
Turnover:3.04M
Market Cap:311.27M
PE:-0.34
High:3.82
Open:3.70
Low:3.52
Close:3.66
52wk High:17.10
52wk Low:1.35
Shares:87.44M
Float Shares:69.55M
Volume Ratio:1.53
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.5034
EPS(LYR):-5.5878
ROE:-156.87%
ROA:-33.54%
PB:5.05
PE(LYR):-0.64

Loading ...

Company Profile

Company Name:
X4 Pharmaceuticals Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
143
Office Location:
61 North Beacon Street,4th Floor,Boston,Massachusetts,United States
Zip Code:
02134
Fax:
- -
Introduction:
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase Ib clinical trial to treat chronic neutropenia and Waldenström macroglobulinemia. The company is also developing X4P-002, a CXCR4 antagonist for the treatment of brain cancers; and X4P-003, a CXCR4 antagonist for the treatment of CXCR4 disorders and primary immunodeficiencies. It has a license agreement with Abbisko Therapeutics Co., Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company is headquartered in Boston, Massachusetts.

Directors

Name
Position
Adam Raymond Craig
Executive Chairman and Principal Executive Officer
Francoise de Craecker
Independent Director
Gary J. Bridger
Independent Director
Michael S. Wyzga
Lead Independent Director
Murray W. Stewart
Independent Director

Shareholders

Name
Position
John Volpone
President and Chief Operating Officer
David H. Kirske
Chief Financial Officer, Secretary and Principal Accounting Officer
Adam Raymond Craig
Executive Chairman and Principal Executive Officer